🧩 Why Some Depression Treatments Work for Some People—But Not Others
The Question Behind So Many Struggles
“Why did the first antidepressant work for my friend and not for me?”
It’s one of the most common and heartbreaking questions we hear—and one filled with both frustration and hope.
You’ve done the therapy. You’ve taken the medication. You’ve shown up. Yet somehow, the relief that others describe still feels out of reach.
Here’s the truth: depression isn’t a one-size-fits-all disorder—and your treatment shouldn’t be either. Understanding why can make the difference between feeling defeated and feeling empowered to try again.
Brain Chemistry Is Unique
For decades, we were told depression came down to a “chemical imbalance”—usually too little serotonin. But modern research paints a more intricate picture.
A 2022 review in Nature found that the serotonin theory of depression is overly simplistic and lacks consistent evidence. Some people with depression actually have normal serotonin levels—yet still experience debilitating symptoms.
Why? Because your brain chemistry and structure are uniquely yours. Research has shown that people who don’t respond to SSRIs (the most common type of antidepressant) often have subtle biological differences—such as variations in their nerve-cell connections or in how their receptors respond to neurotransmitters.
In short, the medication may be perfectly designed—but for someone else’s brain.
“If one key doesn’t open the door, it doesn’t mean the door is locked—it means you might need a different key.”
Different Mechanisms, Different Results
Most antidepressants work on the same basic system: increasing serotonin, norepinephrine, or dopamine in the brain’s synapses. For some, that’s enough to restore balance. For others, those pathways simply aren’t the root cause of their symptoms.
This is where newer options like Spravato and Transcranial Magnetic Stimulation (TMS) come in.
Spravato (esketamine) works through the glutamate system—a completely different brain chemistry route that influences how neurons communicate and form new connections. It’s fast-acting and can “reset” circuits in ways traditional antidepressants can’t.
TMS, on the other hand, uses gentle magnetic pulses to stimulate specific regions of the brain responsible for mood regulation. Think of it as jump-starting a part of your brain that’s been offline—noninvasively, without anesthesia or downtime.
If your depression is rooted in different neurochemical or circuit-based causes, these treatments can open entirely new doors to recovery.
The Many Roads to Depression: Biology, Brain, and Beyond
Depression doesn’t come from a single source. It’s shaped by a combination of biological, neurological, and sociological factors.
-
Biological: genetics, inflammation, hormones, or brain structure differences
-
Neurological: circuit connectivity, neurotransmitter activity, and stress response systems
-
Sociological/Psychological: trauma, isolation, chronic stress, or environmental strain
That’s why two people can share the same diagnosis—but respond to completely different treatments.
For one person, talk therapy and an SSRI might target the right system. For another, the depression might be tied to deeper neurological changes that only respond to neurostimulation or ketamine-based therapy.
When a “standard” treatment doesn’t work, it doesn’t mean you failed—it means your depression has a different fingerprint.
Why It Might Be Time to Try Something New
If you’ve tried multiple antidepressants and rounds of therapy and still feel stuck, you’re not out of options—you’re just ready for a more tailored approach.
TMS and Spravato are both FDA-approved for treatment-resistant depression—the kind that hasn’t improved after standard treatments. These therapies represent a shift toward personalized psychiatry—matching the treatment to your brain’s unique biology and history.
Trying something new isn’t giving up. It’s a sign of courage and self-understanding—of your willingness to keep searching for what truly works for you.
What to Remember
-
It’s normal if the first—or even the fifth—antidepressant doesn’t work.
-
Roughly 30% of people with major depression don’t respond to traditional SSRIs.
-
This doesn’t mean you’re broken. It means your brain needs a different path forward.
-
Treatments like TMS and Spravato exist because of this diversity in brain chemistry.
-
And most importantly: hope isn’t gone—it’s evolving.
You’re not a failed experiment. You’re a unique system we’re learning more about every day.
Your story of healing isn’t about trial and error—it’s about discovery. Each step teaches your care team something new about how your mind and body respond, and every attempt brings you closer to what truly fits.
Closing Thought
At Sonder, we believe depression treatment should never feel like a guessing game—it should feel like a collaboration between your brain, your story, and science.
If you’ve felt defeated by past treatments, know this: there are more routes than ever before. And the one that finally helps you feel like you again might be just ahead.